Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction

American Journal of Cardiology

Volumn 112, Issue 8, 2013, Pages 1158-1164

  Katz, Daniel H ^a   Beussink, Lauren ^a   Sauer, Andrew J ^a   Freed, Benjamin H ^a   Burke, Michael A ^a   Shah, Sanjiv J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

AGED; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ILLINOIS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84884909935     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.061     Document Type: Article

References (28)

1. M. Komajda, P.E. Carson, S. Hetzel, R. McKelvie, J. McMurray, A. Ptaszynska, M.R. Zile, D. Demets, and B.M. Massie Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) Circ Heart Fail 4 2011 27 35
2. M.R. Zile, C.F. Baicu, and W.H. Gaasch Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle N Engl J Med 350 2004 1953 1959
3. M.S. Maurer, D.L. King, L. El-Khoury Rumbarger, M. Packer, and D. Burkhoff Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms J Card Fail 11 2005 177 187
4. A.M. Shah, and M.A. Pfeffer The many faces of heart failure with preserved ejection fraction Nat Rev Cardiol 9 2012 555 556
5. M.S. Maurer, D. Burkhoff, L.P. Fried, J. Gottdiener, D.L. King, and D.W. Kitzman Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study J Am Coll Cardiol 49 2007 972 981
6. M.R. Zile, and M.M. Lewinter Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure J Am Coll Cardiol 49 2007 982 985
7. M. Zile, J. Gottdiener, S. Hetzel, J. McMurray, M. Komajda, R. McKelvie, C. Baicu, B. Massie, P. Carson, and I-PRESERVE Investigators Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction Circulation 124 2011 2491 2501
8. S.F. Mohammed, B.A. Borlaug, V.L. Roger, S.A. Mirzoyev, R.J. Rodeheffer, J.A. Chirinos, and M.M. Redfield Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study Circ Heart Fail 5 2012 710 719
9. V.Y. Anjan, T.M. Loftus, M.A. Burke, N. Akhter, G.C. Fonarow, M. Gheorghiade, and S.J. Shah Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction Am J Cardiol 110 2012 870 876
10. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
11. W.J. Paulus, C. Tschope, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, F.E. Rademakers, P. Marino, O.A. Smiseth, G. De Keulenaer, A.F. Leite-Moreira, A. Borbely, I. Edes, M.L. Handoko, S. Heymans, N. Pezzali, B. Pieske, K. Dickstein, A.G. Fraser, and D.L. Brutsaert How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
12. W.J. Paulus, and J.J. van Ballegoij Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 55 2010 526 537
13. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification J Am Soc Echocardiogr 18 2005 1440 1463
14. C.H. Chen, B. Fetics, E. Nevo, C.E. Rochitte, K.R. Chiou, P.A. Ding, M. Kawaguchi, and D.A. Kass Noninvasive single-beat determination of left ventricular end-systolic elastance in humans J Am Coll Cardiol 38 2001 2028 2034
15. H. Senzaki, C.H. Chen, and D.A. Kass Single-beat estimation of end-systolic pressure-volume relation in humans. A new method with the potential for noninvasive application Circulation 94 1996 2497 2506
16. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc B 1995 289 300
17. K. Wachtell, B. Dahlof, J. Rokkedal, V. Papademetriou, M.S. Nieminen, G. Smith, E. Gerdts, K. Boman, J.N. Bella, and R.B. Devereux Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study Am Heart J 144 2002 1057 1064
18. S. Schwartzenberg, M.M. Redfield, A.M. From, P. Sorajja, R.A. Nishimura, and B.A. Borlaug Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy J Am Coll Cardiol 59 2012 442 451
19. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler, C.S. Moy, M.E. Mussolino, G. Nichol, N.P. Paynter, P.J. Schreiner, P.D. Sorlie, J. Stein, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, M.B. Turner, American Heart Association Statistics Committee, and Stroke Statistics Committee Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
20. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
21. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, S. Anderson, M. Donovan, E. Iverson, C. Staiger, A. Ptaszynska, and I-Preserve Investigators Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
22. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, J. Taylor, and PEP-CHF Investigators The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
23. J.F. Setaro, B.L. Zaret, D.S. Schulman, H.R. Black, and R. Soufer Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance Am J Cardiol 66 1990 981 986
24. R.V. Shah, A.S. Desai, and M.M. Givertz The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis J Card Fail 16 2010 260 267
25. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, J. Ostergren, and CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
26. W.S. Aronow, C. Ahn, and I. Kronzon Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors Am J Cardiol 80 1997 207 209
27. A.O. Conrady, O.G. Rudomanov, D.V. Zaharov, A.N. Krutikov, N.V. Vahrameeva, O.I. Yakovleva, N.P. Alexeeva, and E.V. Shlyakhto Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study Blood Press 13 2004 101 109
28. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, and N. Reichek Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458